{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:47Z","timestamp":1791378167670,"version":"4.3.2"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Fragile X-associated tremor ataxia syndrome (FXTAS) is a multi-faceted and progressive neurodegenerative disorder that manifests clinically with action tremor, gait ataxia, parkinsonism, peripheral neuropathy, and cognitive and psychiatric features. The disease is highly heterogeneous and there are no FDA approved medications for FXTAS as a specific indication. As such, treatment is symptomatic and must be tailored to the specific needs of a given patient. This review provides expert opinion-based treatment recommendations for the core and ancillary clinical features of FXTAS. Movement disorders, such as tremor, ataxia and parkinsonism may respond to symptomatic medications and therapies, but caution is required when considering surgical interventions such as deep brain stimulation. Cognitive decline can be responsive to medications developed for other cognitive disorders, but these medications work best when combined with non-medication based approaches and all patients should be screened for other reversible causes of memory decline. Psychiatric symptoms, including anxiety, depression, and psychosis, can be treated with psychotherapy and medications; but caution is required to avoid exacerbating clinical and subclinical movement disorder features with psychotropic medications. Rehabilitative therapies, such as speech therapy, occupational, and physical therapy, often enhance patient function and quality of life. Exercise and good nutrition are recommendations that are common to other cerebellar ataxias and adult neurodegenerative disorders and may have a positive impact on general health. A multi-disciplinary approach is recommended to address all components of FXTAS.<\/jats:p>","DOI":"10.3389\/fneur.2026.1870779","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:24:37Z","timestamp":1791375877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of fragile X-associated tremor ataxia syndrome: a review for clinicians"],"prefix":"10.3389","volume":"17","author":[{"given":"Deborah A.","family":"Hall","sequence":"first","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Andr\u00e9s","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Klusek","sequence":"additional","affiliation":[{"name":"Department of Communication Sciences and Disorders, University of South Carolina","place":["Columbia, SC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Todd","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan","place":["Ann Arbor, MI, United States"]},{"name":"Veterans Administration Ann Arbor Healthcare System","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan A.","family":"O\u2019Keefe","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nell","family":"Maltman","sequence":"additional","affiliation":[{"name":"Department of Speech, Language and Hearing Sciences, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica Alice Maria","family":"Montanaro","sequence":"additional","affiliation":[{"name":"Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Protic","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scorr","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Turcano","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Seritan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco","place":["San Francisco, CA, United States"]},{"name":"UCSF Weill Institute for Neurosciences","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10048-010-0270-5","article-title":"New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS)","volume":"12","author":"Juncos","year":"2011","journal-title":"Neurogenetics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fgene.2014.00365","article-title":"New observations in the fragile X-associated tremor\/ataxia syndrome (FXTAS) phenotype","volume":"5","author":"Fraint","year":"2014","journal-title":"Front Genet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mds.21252","article-title":"Progression of tremor and ataxia in male carriers of the FMR1 premutation","volume":"22","author":"Leehey","year":"2007","journal-title":"Mov Disord"},{"key":"ref5","first-page":"1","volume-title":"FXTAS, FXPOI, and Other Premutation Disorders","author":"Leehey","year":"2016"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2300052120","DOI":"10.1073\/pnas.2300052120","article-title":"Glial dysregulation in the human brain in fragile X-associated tremor\/ataxia syndrome","volume":"120","author":"Dias","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.26851","article-title":"FXTAS neuropathology includes widespread reactive astrogliosis and White matter specific astrocyte degeneration","volume":"95","author":"Dufour","year":"2024","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/mds.28559","article-title":"Cerebral microbleeds in fragile X-associated tremor\/ataxia syndrome","volume":"36","author":"Salcedo-Arellano","year":"2021","journal-title":"Mov Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"655568","DOI":"10.3389\/fncel.2021.655568","article-title":"Therapeutic development for CGG repeat expansion-associated neurodegeneration","volume":"15","author":"Xu","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","article-title":"Molecular mechanisms underlying nucleotide repeat expansion disorders","volume":"22","author":"Malik","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1056\/NEJMra2300487","article-title":"The spectrum of fragile X disorders","volume":"393","author":"Hagerman","year":"2025","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-33898-9_2","volume-title":"FXTAS, FXPOI, and Other Premutation Disorders","author":"Hall","year":"2016"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/mds.21001","article-title":"Symptomatic treatment of the fragile X-associated tremor\/ataxia syndrome","volume":"21","author":"Hall","year":"2006","journal-title":"Mov Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical phenotype, diagnosis, and treatment","volume":"57","author":"Leehey","year":"2009","journal-title":"J Investig Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.parkreldis.2008.04.037","article-title":"Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease","volume":"15","author":"Hall","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.parkreldis.2014.01.006","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited","volume":"20","author":"Niu","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/mdc3.12708","article-title":"Clinimetric properties of the fragile X-associated tremor ataxia syndrome rating scale","volume":"6","author":"Hall","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence-based review of treatments for essential tremor","volume":"34","author":"Ferreira","year":"2019","journal-title":"Mov Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/WNF.0b013e31816a48e2","article-title":"Levetiracetam improves intention tremor in fragile X-associated tremor\/ataxia syndrome","volume":"32","author":"Saponara","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1007\/s10072-024-07594-6","article-title":"Managing tremor in fragile X-associated tremor\/ataxia syndrome with botulinum neurotoxin: report of a success","volume":"45","author":"Cimmino","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bcr-2023-259452","article-title":"Fragile X-associated tremor\/ataxia syndrome treated with multitarget deep brain stimulation","volume":"17","author":"Okoroafor","year":"2024","journal-title":"BMJ Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pjnns.2016.04.004","article-title":"Deep brain stimulation or thalamotomy in fragile X-associated tremor\/ataxia syndrome? Case report","volume":"50","author":"Tamas","year":"2016","journal-title":"Neurol Neurochir Pol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/mdc3.70068","article-title":"Long-term outcome of unilateral magnetic resonance imaging-guided focused ultrasound for fragile X tremor ataxia syndrome","volume":"12","author":"Di Luca","year":"2025","journal-title":"Mov Disord Clin Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00415-018-8823-x","article-title":"Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming","volume":"265","author":"Artusi","year":"2018","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1212\/WNL.0000000000002982","article-title":"MRI-guided focused ultrasound thalamotomy in fragile X-associated tremor\/ataxia syndrome","volume":"87","author":"Fasano","year":"2016","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1212\/WNL.0000000000001553","article-title":"Long-term improvement of tremor and ataxia after bilateral DBS of VoP\/zona incerta in FXTAS","volume":"84","author":"dos Santos Ghilardi","year":"2015","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000008053","article-title":"Amantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up study","volume":"41","author":"Botez","year":"1999","journal-title":"Eur Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/archneur.1997.00550180059013","article-title":"Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy","volume":"54","author":"Trouillas","year":"1997","journal-title":"Arch Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2007.04.019","article-title":"Treatment of spinocerebellar ataxia with buspirone","volume":"260","author":"Assadi","year":"2007","journal-title":"J Neurol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s007020070032","article-title":"An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment","volume":"107","author":"Hassin-Baer","year":"2000","journal-title":"J Neural Transm (Vienna)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","article-title":"Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial","volume":"74","author":"Ristori","year":"2010","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(21)00457-9","article-title":"Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"21","author":"Coarelli","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1212\/con.0000000000000753","article-title":"Ataxia","volume":"25","author":"Kuo","year":"2019","journal-title":"Continuum"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","article-title":"Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia [RETIRED]: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology","volume":"90","author":"Zesiewicz","year":"2018","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.22240","article-title":"A phase 3 trial of extended release oral dalfampridine in multiple sclerosis","volume":"68","author":"Goodman","year":"2010","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archneur.65.4.495","article-title":"Abnormal nerve conduction features in fragile X premutation carriers","volume":"65","author":"Soontarapornchai","year":"2008","journal-title":"Arch Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"key":"ref40","first-page":"5","article-title":"Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of physical medicine and rehabilitation","volume":"1","author":"England","year":"2009","journal-title":"Neurol J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study","volume":"12","author":"Tolle","year":"2008","journal-title":"Eur J Pain"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"CD007115","DOI":"10.1002\/14651858.cd007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"2015","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/s0140-6736(22)01472-6","article-title":"Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial","volume":"400","author":"Tesfaye","year":"2022","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/pm\/pnaf180","article-title":"Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician","volume":"27","author":"Lawson","year":"2026","journal-title":"Pain Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1440-1789.2008.00948.x","article-title":"Peripheral nervous system pathology in fragile X tremor\/ataxia syndrome (FXTAS)","volume":"29","author":"Gokden","year":"2009","journal-title":"Neuropathology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mds.20753","article-title":"Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study","volume":"21","author":"Louis","year":"2006","journal-title":"Mov Disord"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/archneur.62.6.962","article-title":"FMR1 premutations associated with fragile X-associated tremor\/ataxia syndrome in multiple system atrophy","volume":"62","author":"Biancalana","year":"2005","journal-title":"Arch Neurol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar","volume":"73","author":"Goldberger","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic dysfunction in Parkinson\u2019s disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12311-022-01411-6","article-title":"Symptomatic care in multiple system atrophy: state of the art","volume":"22","author":"Grossauer","year":"2023","journal-title":"Cerebellum"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/ene.70119","article-title":"European academy of neurology (EAN)\/European Federation of Autonomic Societies (EFAS)\/international neuro-urology society (INUS) guidelines for practising neurologists on the assessment and treatment of neurogenic urinary and sexual symptoms (NEUROGED guidelines)","volume":"32","author":"Panicker","year":"2025","journal-title":"Eur J Neurol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/mdc3.70268","article-title":"Approach to cardiovascular autonomic dysfunction in patients with synucleinopathies","volume":"12","author":"Lenka","year":"2025","journal-title":"Mov Disord Clin Pract"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.11124\/JBISRIR-D-18-00005","article-title":"Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly people and people with a neurological condition: a systematic review","volume":"18","author":"Logan","year":"2020","journal-title":"JBI Evid Synth"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"CD012868","DOI":"10.1002\/14651858.cd012868.pub2","article-title":"Fludrocortisone for orthostatic hypotension","volume":"2021","author":"Veazie","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/ajcn\/nqac184","article-title":"The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"van der Schoot","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"qdag176","DOI":"10.1093\/jsxmed\/qdag176","article-title":"A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials","volume":"23","author":"Salonia","year":"2026","journal-title":"J Sex Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"afae126","DOI":"10.1093\/ageing\/afae126","article-title":"Effectiveness of non-pharmacological interventions delivered at home for urinary and faecal incontinence with homebound older people: systematic review of randomised controlled trials","volume":"53","author":"Buck","year":"2024","journal-title":"Age Ageing"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","article-title":"Results of a randomized phase III trial of mirabegron in patients with overactive bladder","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/ijms21124391","article-title":"Fragile X-associated tremor\/ataxia syndrome (FXTAS): pathophysiology and clinical implications","volume":"21","author":"Cabal-Herrera","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0891988716666379","article-title":"Risk factors for cognitive impairment in fragile X-associated tremor\/ataxia syndrome","volume":"29","author":"Seritan","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11689-022-09436-y","article-title":"Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor\/ataxia syndrome","volume":"14","author":"Famula","year":"2022","journal-title":"J Neurodev Disord"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4088\/JCP.13m08546","article-title":"Memantine for fragile X-associated tremor\/ataxia syndrome: a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Seritan","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s13311-017-0555-6","article-title":"Open-label allopregnanolone treatment of men with fragile X-associated tremor\/ataxia syndrome","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e0225191","DOI":"10.1371\/journal.pone.0225191","article-title":"Open-label pilot clinical trial of citicoline for fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"15","author":"Hall","year":"2020","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/cells12242773","article-title":"Open-label sulforaphane trial in FMR1 premutation carriers with fragile-X-associated tremor and ataxia syndrome (FXTAS)","volume":"12","author":"Santos","year":"2023","journal-title":"Cells"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J Alzheimer\u2019s Dis"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"e2220","DOI":"10.1212\/WNL.0000000000011832","article-title":"Long-term effects of cholinesterase inhibitors on cognitive decline and mortality","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1176\/appi.neuropsych.18.2.171","article-title":"Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor\/ataxia syndrome: clinical intervention with donepezil and venlafaxine","volume":"18","author":"Bourgeois","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e45411","DOI":"10.1097\/MD.0000000000045411","article-title":"The imperative for multigenerational genetic screening: a case report of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"104","author":"Huang","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"CD009132","DOI":"10.1002\/14651858.cd009132.pub2","article-title":"Cholinesterase inhibitors for mild cognitive impairment","volume":"2016","author":"Russ","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"107134","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis","volume":"213","author":"Zhang","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1176\/appi.ajp.20230392","article-title":"Cognitive outcomes after antidepressant pharmacotherapy for late-life depression: a systematic review and meta-analysis","volume":"181","author":"Ainsworth","year":"2024","journal-title":"Am J Psychiatry"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11065-018-9369-5","article-title":"A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples","volume":"28","author":"Prado","year":"2018","journal-title":"Neuropsychol Rev"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jagp.2024.08.015","article-title":"A systematic review of antidepressants and psychotherapy commonly used in the treatment of late life depression for their effects on cognition","volume":"33","author":"Nelson","year":"2025","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref77","volume-title":"The ACRM Cognitive Rehabilitation Manual and Textbook","author":"Cicerone","year":"2022"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/6645554","article-title":"Efficacy and feasibility of remote cognitive remediation therapy in Parkinson\u2019s disease: a randomized controlled trial","volume":"2023","author":"Hoffman","year":"2023","journal-title":"Parkinsons Dis"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/geronb\/gbab007","article-title":"Cognitive stimulation therapy for older adults with mild-to-moderate dementia in Italy: effects on cognitive functioning, and on emotional and neuropsychiatric symptoms","volume":"76","author":"Carbone","year":"2021","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4103\/neurol-india.Neurol-India-D-23-00513","article-title":"Efficacy of cognitive interventions in mild cognitive impairment due to Alzheimer\u2019s disease-an open-labelled exploratory analysis","volume":"72","author":"Rajesh","year":"2024","journal-title":"Neurol India"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"102312","DOI":"10.1016\/j.arr.2024.102312","article-title":"Effectiveness of cognitive stimulation therapy (CST) for mild to moderate dementia: a systematic literature review and meta-analysis of randomised control trials using the original CST protocol","volume":"97","author":"Desai","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v67n0112","article-title":"Psychiatric phenotype of the fragile X-associated tremor\/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia","volume":"67","author":"Bacalman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4088\/JCP.09m05407blu","article-title":"Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers","volume":"72","author":"Bourgeois","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1573400511309010009","article-title":"Psychiatric disorders associated with FXTAS","volume":"9","author":"Seritan","year":"2013","journal-title":"Curr Psychiatr Rev"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/appi.neuropsych.21110282","article-title":"A systematic review of fragile X-associated neuropsychiatric disorders","volume":"35","author":"Flavell","year":"2023","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome \u2014 features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/da.22854","article-title":"Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders","volume":"36","author":"Jakubovski","year":"2019","journal-title":"Depress Anxiety"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1176\/appi.ajp.2015.15030331","article-title":"Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder","volume":"173","author":"Jakubovski","year":"2016","journal-title":"Am J Psychiatry"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CIA.S1794","article-title":"Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems","volume":"3","author":"Hagerman","year":"2008","journal-title":"Clin Interv Aging"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/WCO.0000000000000954","article-title":"Fragile X-associated tremor\/ataxia syndrome: pathophysiology and management","volume":"34","author":"Hagerman","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/ph17101278","article-title":"Drug\u2013drug interactions of selective serotonin reuptake inhibitors: a pharmacovigilance study on real-world evidence from the EudraVigilance database","volume":"17","author":"Dobrea","year":"2024","journal-title":"Pharmaceuticals"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study","volume":"163","author":"Dalton","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation","volume":"75","author":"Beach","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hup.1074","article-title":"Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy","volume":"25","author":"Dell\u2019Osso","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/164","article-title":"Serotonin and norepinephrine reuptake inhibitors","volume":"250","author":"Shelton","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"ref97","first-page":"287","article-title":"Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms","volume":"57","author":"Sramek","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-012-2251-x","article-title":"A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors","volume":"136","author":"Lavigne","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J Affect Disord"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1176\/appi.neuropsych.20230215","article-title":"Psychiatric manifestations in early to middle stages of fragile X-associated tremor-ataxia syndrome (FXTAS)","volume":"37","author":"Chi","year":"2025","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2023-300951","article-title":"Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials","volume":"27","author":"Cohen","year":"2024","journal-title":"BMJ Ment Health"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref104","first-page":"181","author":"Hall","year":"2016"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"720253","DOI":"10.3389\/fnins.2021.720253","article-title":"Case report: coexistence of Alzheimer-type neuropathology in fragile X-associated tremor ataxia syndrome","volume":"15","author":"Salcedo-Arellano","year":"2021","journal-title":"Front Neurosci"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062825","article-title":"Premutation females with preFXTAS","volume":"26","author":"Liani","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJMoa2034634","article-title":"Trial of pimavanserin in dementia-related psychosis","volume":"385","author":"Tariot","year":"2021","journal-title":"N Engl J Med"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jad.2020.06.021","article-title":"Improvements in irritability with sertraline versus placebo: findings from the EMBARC study","volume":"275","author":"Jha","year":"2020","journal-title":"J Affect Disord"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/08919887251369893","article-title":"Efficacy and safety of escitalopram and citalopram for agitation in Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"da Silva","year":"2026","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jagp.2021.04.014","article-title":"Low dose Lithium treatment of behavioral complications in Alzheimer\u2019s disease: Lit-AD randomized clinical trial","volume":"30","author":"Devanand","year":"2022","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jnnp.2006.100222","article-title":"Movement disorders in patients taking anticonvulsants","volume":"78","author":"Zadikoff","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jagp.2024.05.004","article-title":"Anticonvulsants in the treatment of behavioral and psychological symptoms in dementia: a systematic review","volume":"32","author":"Benjamin","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"15333175221081374","DOI":"10.1177\/15333175221081374","article-title":"Adverse outcomes associated with off-label agents used to treat dementia patients with psychosis: a case-control Medicare database study","volume":"37","author":"Rashid","year":"2022","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3390\/cells12182330","article-title":"Insight and recommendations for fragile X-premutation-associated conditions from the fifth international conference on FMR1 premutation","volume":"12","author":"Tassone","year":"2023","journal-title":"Cells"},{"key":"ref115","volume-title":"Cognitive Behavior Therapy: Basics and Beyond","author":"Beck","year":"2011"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"42164","DOI":"10.1038\/s41598-025-25959-5","article-title":"Swallowing and choking difficulties as potential markers of FXTAS progression in FMR1 premutation carriers","volume":"15","author":"Likhitweerawong","year":"2025","journal-title":"Sci Rep"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2020.08.001","article-title":"Dysphagia in older adults","volume":"96","author":"Thiyagalingam","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.mcna.2021.05.013","article-title":"Dysphagia and swallowing disorders","volume":"105","author":"McCarty","year":"2021","journal-title":"Med Clin North Am"},{"key":"ref119","first-page":"97","article-title":"Dysphagia: evaluation and collaborative management","volume":"103","author":"Wilkinson","year":"2021","journal-title":"Am Fam Physician"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.3390\/jcm14207180","article-title":"Evaluating behavioural interventions for oropharyngeal dysphagia in adults: a systematic review and meta-analysis of swallowing manoeuvres, exercises, and postural techniques","volume":"14","author":"Silvia","year":"2025","journal-title":"J Clin Med"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11357-024-01389-5","article-title":"Efficacy of swallowing rehabilitative therapies for adults with dysphagia: a network meta-analysis of randomized controlled trials","volume":"47","author":"Lee","year":"2025","journal-title":"Geroscience"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.jnha.2025.100486","article-title":"Effectiveness of diet modification on dietary nutrient intake, aspiration, and fluid intake for adults with dysphagia: a meta-analysis of randomized controlled trials","volume":"29","author":"Chu","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm11123521","article-title":"Effects of Oral health interventions in people with oropharyngeal dysphagia: a systematic review","volume":"11","author":"Remijn","year":"2022","journal-title":"J Clin Med"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1044\/2020_AJSLP-19-00136","article-title":"Shifting tides toward a proactive patient-centered approach in dysphagia management of neurodegenerative disease","volume":"29","author":"Rogus-Pulia","year":"2020","journal-title":"Am J Speech Lang Pathol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/lary.20702","article-title":"Clinical characteristics of essential voice tremor: a study of 34 cases","volume":"120","author":"Sulica","year":"2010","journal-title":"Laryngoscope"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/mdc3.14061","article-title":"Widening the phenotype of fragile-X tremor ataxia syndrome in females: spasmodic dysphonia in two patients","volume":"11","author":"Khan","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/mds.21571","article-title":"Expanding the phenotype of fragile X-associated tremor\/ataxia syndrome: a new female case","volume":"22","author":"Horvath","year":"2007","journal-title":"Mov Disord"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jvoice.2024.03.027","article-title":"Noninvasive management of voice disorders: an umbrella review","volume":"40","author":"Garabet","year":"2026","journal-title":"J Voice"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"381.e11","DOI":"10.1016\/j.jvoice.2017.12.015","article-title":"Effectiveness of voice therapy associated with electromyographic biofeedback in women with behavioral dysphonia: randomized placebo-controlled double-blind clinical trial","volume":"33","author":"Ribeiro","year":"2019","journal-title":"J Voice"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1044\/2025_AJSLP-25-00009","article-title":"Effects of respiratory lung volume training on speech breathing, voice, and vocal function: a randomized controlled trial","volume":"34","author":"Lowell","year":"2025","journal-title":"Am J Speech Lang Pathol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/wjo2.70011","article-title":"Treatment of neurogenic voice disorders","volume":"11","author":"Syamal","year":"2025","journal-title":"World J Otorhinolaryngol \u2013 Head and Neck Surg"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"20707","DOI":"10.1038\/s41598-024-70810-y","article-title":"Language use predicts symptoms of fragile X-associated tremor\/ataxia syndrome in men and women with the FMR1 premutation","volume":"14","author":"Maltman","year":"2024","journal-title":"Sci Rep"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.neuropsych.19020044","article-title":"Speech and language therapy for voice problems in Parkinson\u2019s disease: a Meta-analysis","volume":"32","author":"Xu","year":"2020","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1044\/2023_ajslp-23-00274","article-title":"Behavioral management of respiratory\/phonatory dysfunction for dysarthria associated with neurodegenerative disease: a systematic review","volume":"33","author":"Perry","year":"2024","journal-title":"Am J Speech Lang Pathol"},{"key":"ref135","volume-title":"Motor Speech Disorders: Substrates, Differential Diagnosis, and Management","author":"Duffy","year":"2012"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.gimo.2023.100829","article-title":"Social and physical predictors of mental health impact in adult women who have an FMR1 premutation","volume":"1","author":"Kraan","year":"2023","journal-title":"Genet Med O"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.neurobiolaging.2010.09.002","article-title":"Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome","volume":"33","author":"Schneider","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/CIA.S240314","article-title":"Rapidly progressing neurocognitive disorder in a male with FXTAS and Alzheimer\u2019s disease","volume":"15","author":"Aydin","year":"2020","journal-title":"Clin Interv Aging"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/jcm13020504","article-title":"Case series: vestibular migraines in fragile X premutation carriers","volume":"13","author":"Tak","year":"2024","journal-title":"J Clin Med"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00405-026-10058-6","article-title":"Efficacy of a structured auditory training module in older individuals with hearing loss: a randomized controlled trial","volume":"283","author":"Gundmi","year":"2026","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1044\/2026_JSLHR-25-00737","article-title":"Effects of hearing devices for adults with mild-to-severe hearing loss: a systematic review and Meta-analysis of randomized controlled trials","volume":"69","author":"Pandey","year":"2026","journal-title":"J Speech Lang Hear Res"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3766\/jaaa.16067","article-title":"Tinnitus management: randomized controlled trial comparing extended-Wear hearing aids, conventional hearing aids, and combination instruments","volume":"28","author":"Henry","year":"2017","journal-title":"J Am Acad Audiol"},{"key":"ref143","volume-title":"Tinnitus: Assessment and Management","year":"2020"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamaoto.2013.1744","article-title":"Cochlear implantation in adults: a systematic review and meta-analysis","volume":"139","author":"Gaylor","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gaitpost.2018.09.005","article-title":"Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor\/ataxia syndrome","volume":"66","author":"O\u2019Keefe","year":"2018","journal-title":"Gait Posture"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1007\/s00415-020-09938-6","article-title":"Balance and coordination training for patients with genetic degenerative ataxia: a systematic review","volume":"268","author":"He","year":"2021","journal-title":"J Neurol"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2147\/CIA.S531235","article-title":"Balance and gait disorders in the aged population: causes, assessment and management: a literature review","volume":"20","author":"Manckoundia","year":"2025","journal-title":"Clin Interv Aging"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5014\/ajot.2012.005017","article-title":"Systematic review of the effect of home modification and fall prevention programs on falls and the performance of community-dwelling older adults","volume":"66","author":"Chase","year":"2012","journal-title":"Am J Occup Ther"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/DBP.0b013e3181c35f25","article-title":"Broad clinical involvement in a family affected by the fragile X premutation","volume":"30","author":"Chonchaiya","year":"2009","journal-title":"Develop Behav Peds"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s12311-015-0659-7","article-title":"Characterization and early detection of balance deficits in fragile X premutation carriers with and without fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"14","author":"O\u2019Keefe","year":"2015","journal-title":"Cerebellum"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/s24082586","article-title":"Potential prodromal digital postural sway markers for fragile X-associated tremor\/ataxia syndrome (FXTAS) detected via dual-tasking and sensory manipulation","volume":"24","author":"Timm","year":"2024","journal-title":"Sensors (Basel)"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1491142","DOI":"10.3389\/fneur.2024.1491142","article-title":"Effects of physiotherapy on degenerative cerebellar ataxia: a systematic review and meta-analysis","volume":"15","author":"Matsugi","year":"2024","journal-title":"Front Neurol"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.gaitpost.2014.04.190","article-title":"Gait adaptability training improves obstacle avoidance and dynamic stability in patients with cerebellar degeneration","volume":"40","author":"Fonteyn","year":"2014","journal-title":"Gait Posture"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2854130","article-title":"Biofeedback based home balance training can improve balance but not gait in people with multiple sclerosis","volume":"2019","author":"Novotna","year":"2019","journal-title":"Mult Scler Int"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12984-019-0522-z","article-title":"Effects of repeated waist-pull perturbations on gait stability in subjects with cerebellar ataxia","volume":"16","author":"Aprigliano","year":"2019","journal-title":"J Neuroeng Rehabil"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/02692155251394944","article-title":"Effects of dual-task training on walking and balance in stroke patients: a systematic review and network meta-analysis","volume":"40","author":"Zhao","year":"2025","journal-title":"Clin Rehabil"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0b013e3181c33adf","article-title":"Intensive coordinative training improves motor performance in degenerative cerebellar disease","volume":"73","author":"Ilg","year":"2009","journal-title":"Neurology"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"583507","DOI":"10.1155\/2014\/583507","article-title":"Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames","volume":"2014","author":"Synofzik","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12311-013-0531-6","article-title":"Consensus paper: management of degenerative cerebellar disorders","volume":"13","author":"Ilg","year":"2014","journal-title":"Cerebellum"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.1038\/s41598-018-26109-w","article-title":"A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7172686","article-title":"Partial body weight-supported treadmill training in spinocerebellar ataxia","volume":"2018","author":"de Oliveira","year":"2018","journal-title":"Rehabil Res Pract"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/09593980903532234","article-title":"Use of trunk stabilization and locomotor training in an adult with cerebellar ataxia: a single system design","volume":"26","author":"Freund","year":"2010","journal-title":"Physiother Theory Pract"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00415-013-6910-6","article-title":"The effectiveness of allied health care in patients with ataxia: a systematic review","volume":"261","author":"Fonteyn","year":"2014","journal-title":"J Neurol"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/1545968311425918","article-title":"Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases","volume":"26","author":"Miyai","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/09593985.2022.2037115","article-title":"Effects of therapeutic exercise on disease severity, balance, and functional independence among individuals with cerebellar ataxia: a systematic review with meta-analysis","volume":"39","author":"Winser","year":"2023","journal-title":"Physiother Theory Pract"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"21997","DOI":"10.1038\/s41598-025-01990-4","article-title":"Impact of rehabilitation on quality of life in patients with degenerative cerebellar ataxias using structural equation modeling","volume":"15","author":"Haruyama","year":"2025","journal-title":"Sci Rep"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/NPT.0000000000000090","article-title":"Motor-cognitive dual-task training in persons with neurologic disorders: a systematic review","volume":"39","author":"Fritz","year":"2015","journal-title":"J Neurol Phys Ther"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0269215520941142","article-title":"Dual-task training on gait, motor symptoms, and balance in patients with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"34","author":"Li","year":"2020","journal-title":"Clin Rehabil"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.apmr.2022.11.001","article-title":"Effects of dual task training on dual task gait performance and cognitive function in individuals with Parkinson disease: a meta-analysis and meta-regression","volume":"104","author":"Wong","year":"2023","journal-title":"Arch Phys Med Rehabil"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1267099","DOI":"10.3389\/fneur.2023.1267099","article-title":"Effectiveness and cost of integrated cognitive and balance training for balance and falls in cerebellar ataxia: a blinded two-arm parallel group RCT","volume":"14","author":"Winser","year":"2023","journal-title":"Front Neurol"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"359","DOI":"10.14283\/jpad.2022.16","article-title":"The effects of dual-task training on cognitive and physical functions in older adults with cognitive impairment; a systematic review and meta-analysis","volume":"9","author":"Ali","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181e39696","article-title":"Dual-task performances can be improved in patients with dementia: a randomized controlled trial","volume":"74","author":"Schwenk","year":"2010","journal-title":"Neurology"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12311-020-01199-3","article-title":"The effects of dual task cognitive interference and fast-paced walking on gait, turns, and falls in men and women with FXTAS","volume":"20","author":"O\u2019Keefe","year":"2021","journal-title":"Cerebellum"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/978-3-031-24345-5_26","volume-title":"Trials for Cerebellar Ataxias: From Cellular Models to Human Therapies","author":"Robertson","year":"2023"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1177\/1545968309336146","article-title":"Randomized clinical trial of balance-based torso weighting for improving upright mobility in people with multiple sclerosis","volume":"23","author":"Widener","year":"2009","journal-title":"Neurorehabil Neural Repair"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1017\/S0033291720003670","article-title":"Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis","volume":"50","author":"Begemann","year":"2020","journal-title":"Psychol Med"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.gerinurse.2024.07.013","article-title":"Systematic review and meta-analysis of transcranial direct current stimulation (tDCS) for global cognition in mild cognitive impairment and Alzheimer\u2019s disease","volume":"59","author":"Hou","year":"2024","journal-title":"Geriatr Nurs"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"e6976","DOI":"10.7759\/cureus.6976","article-title":"Low vitamin B12 levels: an underestimated cause of minimal cognitive impairment and dementia","volume":"12","author":"Jatoi","year":"2020","journal-title":"Cureus"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jalz.2015.04.011","article-title":"MIND diet slows cognitive decline with aging","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jshs.2021.05.003","article-title":"Comparative efficacy of various exercise interventions on cognitive function in patients with mild cognitive impairment or dementia: a systematic review and network meta-analysis","volume":"11","author":"Huang","year":"2022","journal-title":"J Sport Health Sci"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamaneurol.2025.3421","article-title":"Home training for cerebellar ataxias: a randomized clinical trial","volume":"82","author":"Barbuto","year":"2025","journal-title":"JAMA Neurol"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"100540","DOI":"10.1016\/j.arrct.2025.100540","article-title":"Changes in gait after training for individuals with cerebellar ataxia","volume":"7","author":"Smani","year":"2025","journal-title":"Arch Rehabil Res Clin Transl"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1870779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:24:42Z","timestamp":1791375882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1870779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":182,"alternative-id":["10.3389\/fneur.2026.1870779"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1870779","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1870779"}}